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Abstract
Background:  Expression of transgenes in mice requires transcriptional regulatory elements that
direct expression in a chosen cell type. Unfortunately, the availability of well-characterized
promoters that direct bona-fide expression of transgenes in transgenic mice is limited. Here we
described a method that allows highly efficient targeting of transgenes to a preselected locus in ES
cells.
Results:  A pgk-LoxP-Neo cassette was introduced into a desired genomic locus by homologous
recombination in ES cells. The pgk promoter was then removed from the targeted ES cells by Cre
recombinase thereby restoring the ES cells' sensitivity to G418. We demonstrated that transgenes
could be efficiently introduced into this genomic locus by reconstituting a functional Neo gene.
Conclusion:  This approach is simple and extremely efficient in facilitating the introduction of
single-copy transgenes into defined genomic loci. The availability of such an approach greatly
enhances the ease of using endogenous regulatory elements to control transgene expression and,
in turn, expands the repertoire of elements available for transgene expression.
Introduction
The study of gene function has been greatly advanced
through the use of transgenic mice. Over-expression and
ectopic expression of transgenes, as well as the expres-
sion of genetic variants, has facilitated the deciphering of
complex cellular processes as well as the generation of
animal models of disease. More recently, transgenic
mice have also been used to express Cre recombinase to
mediate the conditional deletion of loxP-flanked DNA
sequences in specific cell types in vivo. Traditional meth-
ods for generating transgenic mice require the availabil-
ity of well characterized transcriptional regulatory
elements, promoters or enhancers, that direct transgene
expression in specific cell types. For example, Surfactant
protein C regulatory elements have been used extensive-
ly to drive high level expression of transgenes in the lung
[1,2,3,4]. Similarly, Transthyretin regulatory elements
confer expression of transgenes in the liver [5, 6]. Unfor-
tunately, the number well-characterized enhancers/pro-
moters available for transgene expression is limited. This
is due to the fact that, although in situ hybridization and
RNA blotting techniques can rapidly characterize the ex-
pression patterns of genes, the identification of regulato-
ry elements that control cell type-specific expression in
animals is extremely laborious. An additional complica-
tion associated with traditional transgenic approaches is
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that the number and genomic location of transgene inte-
gration events is random. This can have a significant im-
pact on both the level and site of transgene expression.
These problems can be circumvented, however, by utiliz-
ing endogenous regulatory elements. This can be
achieved by introducing transgenes into defined genom-
ic loci through homologous recombination in ES cells
("knock-in") [7]. While this approach requires knowl-
edge of the gene expression pattern it does not require
any analysis of gene regulatory elements. Such a "knock-
in" approach would, in effect, significantly increase the
repertoire of regulatory elements available to drive
transgene expression. Moreover, it ensures that a single
copy of the transgene is introduced into a defined ge-
nomic location. The introduction of LacZ into specific
genes during the generation of knockout mice has dem-
onstrated that such an approach can be successful [8, 9].
The downside, however, is that every individual trans-
gene an investigator wishes to express must be inde-
pendently targeted to the chosen genomic locus. This can
be tedious, especially if the rate of recombination at the
chosen genomic locus is low. Here, we describe a simple
method that allows transgenes targeted to a marked ge-
nomic locus to be selected with extremely high efficiency
in ES cells. This approach is also appealing because it re-
lies on reconstitution of active neomycin phosphotrans-
ferase activity, and so correctly targeted ES cell clones
can be simply selected by growth in G418.
Results
Fig 1 illustrates the overall strategy that we have used to
introduce single copy transgenes into a defined genomic
locus. For convenience the procedure can be considered
in three distinct steps. First a specific genomic locus is
chosen based on known gene expression data. In the ex-
ample presented here we chose the Hnf3α  locus because
Hnf3α  is expressed throughout the embryonic gut endo-
derm of the mouse and our ultimate objective is to assess
the function of transgenes expressed in this tissue
[10,11,12,13]. In addition, mice lacking a single Hnf3α  al-
lele have no observable phenotype, so that introduction
of transgenes into this locus will not inherently affect
embryonic development [14, 15]. Once the locus is cho-
sen a targeting vector is designed to introduce a pgk/
loxP-Neo cassette that confers resistance to G418 in
mammalian cells. Importantly, the pgk promoter of this
cassette is flanked by loxP elements so that the promoter
can easily be removed using Cre recombinase. In step 2 a
Cre-expression plasmid is transiently introduced into
the pgk/loxP-Neo targeted ES cells. Cre-mediated dele-
tion of the pgk promoter results in the cells reverting to
G418 sensitivity while retaining the Neo gene. Step 2 is
rapid and straightforward because Cre-mediated recom-
bination is extremely efficient. The generation of these
G418-sensitive ES cells containing Neo integrated into
the Hnf3α  locus form the basis for targeting transgenes
to this locus.
In step 3, a general targeting vector is constructed that
will allow the introduction of transgenes to the Hnf3α /
Neo locus. The salient features of such a vector are shown
in Fig 2. A unique SalI restriction endonuclease site al-
lows the introduction of coding sequences into this vec-
tor. A 3' splice site and polyadenylation signal has been
incorporated to facilitate proper post-transciptional
processing of transgenes. Targeting of transgenes to the
Hnf3α /Neo locus is mediated by two arms of homology.
The 3' arm of homology contains nucleotides 29 to 626 of
the Neo coding sequence with an accompanying pgk pro-
moter flanked by loxP elements. No G418 resistant colo-
nies were obtained when plasmids containing this
truncated Neo cassette were introduced into wild type ES
cells by electroporation (data not shown). This con-
firmed that deletion of the 3'-end of Neo results in loss of
resistance to G418 [16]. The 5' region of homology con-
sisted of 4.5 kb of Hnf3α  genomic sequence that extends
into sequences encoding the untranslated 5' leader re-
gion of Hnf3α  mRNA [17]. These sequences ensure that
the site of transcriptional initiation remains intact after
transgenes have been targeted to the Hnf3α  locus [17].
To ascertain whether the strategy proposed in Fig 1 was
feasible and to determine the efficiency of such an ap-
proach we attempted to introduce a lacZ transgene into
the Hnf3α  locus. The genotype of ES cell clones from
each step of the procedure was determined by Southern
blot analysis of genomic DNA (Fig 3). Figs 3a and 3b
show that the genotype of ES cells at each stage of the
procedure could be distinguished by genomic Southern
blot analysis using a single DNA probe (probe A) to iden-
tify a Hind III/EcoRV restriction endonuclease fragment
that was specific to each targeted allele. In step1 we intro-
duced a pgkloxP-Neo cassette into the Hnf3α  locus fol-
lowing the procedure described in materials and
methods. Fig 3b shows that probe A identifies an 8.0 kb
Hind III/EcoRV fragment in wild type ES cells. Target-
ing of a pgkloxP-Neo cassette to this locus introduces a
unique  EcoRV site that generates a 4.0 kb HindIII/
EcoRV fragment also detected by probe A. We obtained
four correctly targeted ES cell clones out of 200 that were
resistant to both G418 and gancyclovir (Fig 3b). In addi-
tion to the data shown in Fig 3b, the genotype of these
colonies was confirmed by Southern blot using DNA
fragments that corresponded to 3' Hnf3α  genomic se-
quences and to Neo (not shown). These correctly target-
ed ES cell clones were called Hnf3α loxPNeo clones 1-4 to
indicate that a pgkloxP-Neo cassette had been intro-
duced into the Hnf3α  locus. Next, a plasmid that ex-
presses Cre-recombinase in mammalian cells was
introduced into Hnf3α loxPNeo ES cells by transientBMC Developmental Biology (2001) 1:10 http://www.biomedcentral.com/1471-213X/1/10
Figure 1
Strategy used to introduce transgenes into a defined genomic locus in ES cells. For convenience the approach can be consid-
ered in three steps (boxes). In step1, a cassette containing neomycin phosphotransferase coding sequence (Neo, green) that is
expressed from a phosphoglycerate kinase-1 (pgk) promoter (light blue) flanked by loxP elements (red) is targeted to a chosen
locus, in this case Hnf3α  (yellow), by homologous recombination. Cells containing the Neo cassette are resistant to the phar-
macological inhibitor G418. In step 2, sensitivity of the targeted ES cells to G418 is restored by removing the Pgk promoter by
transiently introducing a plasmid that expresses Cre recombinase. In step 3, transgenes (dark blue) are introduced to the locus
through homologous recombination. The short arm of homology contains a truncated Neo gene (∆ Neo) that lacks phospho-
transferase activity that can be expressed from a Pgk promoter. The long arm of homology consists of genomic DNA
sequences lying 5' to the intended site of integration (not drawn to scale). Homologous recombination reconstitutes expres-
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transfection (materials and methods). The expression of
Cre recombinase mediated recombination between the
loxP elements that flanked the pgk promoter. Southern
blot analysis (fig 3) shows that deletion of the pgk pro-
moter in Hnf3α loxPNeo cells generated a predicted 3.5
kb HindIII/EcoRV fragment that was detected by probe
A. Moreover, Fig 3c shows that deletion of the pgk pro-
moter resulted in the Hnf3α loxPNeo cells reverting to
G418-sensitivity because the promoter is necessary for
Neo expression. The pgk promoter was deleted from 25%
of transfected Hnf3α loxPNeo ES cells, using the ap-
proach described in materials and methods. ES cell lines
from which the pgk promoter had been deleted were
named Hnf3α∆ pgk-Neo to indicate this event.
Our ultimate goal is to target a number of different trans-
genes to the Hnf3α  locus with the aim of expressing them
ectopically throughout the embryonic gut endoderm. To
facilitate this we have designed a general targeting vector
that can accommodate and allow expression of any open
reading frame when targeted to the Hnf3α  locus in
Hnf3α∆ pgk-Neo ES cells. There are a number of impor-
tant features associated with this vector that are illustrat-
ed in Fig 2. This plasmid includes a unique SalI
restriction endonuclease cut-site for insertion of open
reading frames, followed by intron and poly- [A] addi-
tion sequences for correct post-transcriptional process-
ing of transgenic RNA. The 5' arm of homology within
the targeting vector defines where the transgene is posi-
tioned relative to the Hnf3α  locus. We maintained the in-
tegrity of the endogenous Hnf3α  transcriptional start-
site to ensure bona-fide expression of any inserted trans-
gene. This was achieved by using a 5' arm of homology
whose 3' end lay within genomic sequences encoding the
untranslated leader of the Hnf3α  mRNA (Fig 2) [17]. The
3' arm of homology consisted of the 5' end of Neo coding
sequence accompanied by the pgk promoter with flank-
ing loxP elements. This Neo fragment lacked sequences
encoding the last 49 amino acids of neomycin phospho-
transferase. Such truncation of the Neo gene disrupted
its ability to encode resistance to G418 confirming the re-
sults of Beck et al (data not shown) [16]. Therefore, ES
cells that randomly integrate this targeting vector would
remain sensitive to G418. In contrast, we predicted that
homologous recombination between the truncated Neo
sequences in the targeting vector and Neo sequences
within Hnf3α∆ pgk-Neo ES cells would reconstitute ex-
pression of active neomycin phosphotransferase and so
confer resistance to G418. This in turn implies that, fol-
lowing electroporation of this targeting vector into
Hnf3α∆ pgk-Neo ES cells, 100% of G418 resistant colo-
nies would have undergone homologous recombination.
To test this prediction we generated a targeting vector
that contained the LacZ gene from E.coli. Homologous
recombination should place expression of this transgene
under the control of Hnf3α  transcriptional regulatory el-
ements. This plasmid was introduced into Hnf3α∆ pgk-
Neo ES cells by electroporation and fifteen colonies were
collected that were resistant to G418. The genotype of the
colonies was again ascertained by Southern blot analysis
of genomic DNA. Fig 3α  shows that introduction of the
LacZ transgene into the Hnf3α  locus was predicted to
generate a 2.7 kb HindIII/EcoRV fragment that interacts
with probe A. Fig 4 shows that fifteen out of fifteen ES
cell lines that were resistant to G418 had undergone ho-
mologous recombination and contained the LacZ trans-
gene correctly targeted to the Hnf3α  locus. These data
confirm the extraordinary efficiency of using this ap-
proach to target transgenes to a marked genomic locus.
We predicted that transgenes inserted into the Hnf3α  lo-
cus would be expressed throughout the endoderm of the
developing gut. To determine if this was true we generat-
ed embryos from ES cells containing LacZ at the Hnf3α
locus (Hnf3α LacZ ES cells) and stained for expression of
β -galactosidase. Mouse embryos derived solely from ES
cells were generated by tetraploid aggregation as de-
scribed previously [18,19,20]. A total of 10 embryos were
produced and all showed the same pattern of β -galactos-
idase expression. Fig 4b shows β -galactosidase staining
in Hnf3α LacZ embryos at 10.5 days of embryonic devel-
opment. As expected, β -galactosidase was expressed
throughout the gut, liver and at particularly high levels in
the developing stomach. Endogenous Hnf3α  is also ex-
pressed in the floorplate of the neural tube as well as the
notochord. However, expression of β -galactosidase in
Hnf3α LacZ transgenic embryos was undetectable in
these tissues. In generating the Hnf3α LacZ targeting
Figure 2
Schematic of a general targeting vector used to introduce
transgenes into the Hnf3α  locus by homologous recombina-
tion. The 5' arm of homology contains Hnf3α  genomic DNA
that extends 3' of the Hnf3α  transcriptional start-site
(arrow). Coding sequences can be introduced into a unique
Sal1 site that lies 5' to sequences containing an intron and
polyadenylation signal for efficient RNA processing. A trun-
cated Neo gene (∆ Neo) that lacks phosphotransferase activ-
ity provides the short arm of homology. Expression of ∆ Neo
is regulated by a Pgk promoter flanked by loxP elements. For
electroporation into ES cells the targeting vector can be
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vector we deleted all genomic sequences lying 3' to the
first intron of the Hnf3α  gene. It is likely that this intron
or other untranslated sequences contain regulatory ele-
ments that specifically direct expression of Hnf3α LacZ
in the floorplate of the neural tube and notochord [21].
Indeed when LacZ is introduced into exon 2 in ES cells,
leaving the first intron intact, expression of β -galactosi-
dase is readily detectable in the neural-tube floorplate
and notochord [9].
Discussion and conclusions
We have described a method that allows transgenes to be
easily targeted to a defined locus in the mouse genome in
ES cells. Although this is a multiple-step procedure, once
the chosen locus has been targeted using homologous re-
combination, subsequent manipulations are extremely
efficient. Indeed in the final step, where the transgene of
interest is targeted to the desired locus, we found that
100% of G418 resistant ES cell colonies were correctly
targeted. Transgenic mice and embryos can be generated
from these ES cells by standard injection into blastocysts
Figure 3
Genotype and G418 resistance of ES cells harboring insertions at the Hnf3α  locus. a) A schematic showing the relative position
of HindIII and EcoRV restriction endonuclease cut sites at the Hnf3α  locus in ES cells. The predicted endonuclease fragment
sizes identified by probe A (line) are shown above. Hnf3α  E S  c e l l s  h a v e  a  w i l d  t y p e  Hnf3α  locus (Hnf3α , wt) and
Hnf3α loxPNeo ES cells have a PgkloxP-Neo cassette introduced into a single Hnf3α  allele. The pgk promoter was deleted from
Hnf3α loxPNeo ES cells using Cre recombinase to generate G418 sensitive Hnf3α∆ pgk-Neo ES cells. Hnf3α LacZ ES cells were
generated by the introduction of a LacZ transgene into the Hnf3α∆ pgk-Neo locus of Hnf3α∆ pgk-Neo ES cells by homologous
recombination. b) Southern blot of HindIII/EcoRV-digested genomic DNA isolated from Hnf3α , Hnf3α loxPNeo, Hnf3α∆ pgk-
Neo, and Hnf3α  LacZ ES cells. Probe A identified an 8.0 kb wild type fragment in Hnf3α  ES cells (lane 1). In Hnf3α loxPNeo
(lane 2), Hnf3α∆ pgk-Neo (lane 3), and Hnf3α  LacZ (lane 4) ES cells probe A hybridized to an additional fragment of 4.0, 3.5
and 2.7 kb, respectively, due to the introduction of a novel EcoRV restriction endonuclease cut site. c) Hnf3α , Hnf3α loxPNeo,
Hnf3α∆ pgk-Neo, and Hnf3α  LacZ ES cells were cultured in the absence (-G418) or presence (+G418) of 300 µg/ml of G418.
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and subsequent breeding of the resulting chimeric mice.
It is worth noting, however, that if germline transmission
is the aim of the experiment it is important to ensure that
the "∆ pgk-Neo" cells generated in step 2 are germline
competent. This is important because each round of
clonal selection increases the likelihood of losing germ-
line competency of the ES cells.
The targeting of transgenes into a given locus has a
number of advantages over traditional methods of gener-
ating transgenic mice. Traditionally, transgenic mice are
produced by injection of DNA into the male pronucleus
of fertilized mouse eggs. A variable number of copies of
the transgene are then integrated into the mouse genome
at random locations. The position and number of trans-
gene copies can have a profound effect on their expres-
sion. In some cases expression is repressed or, in
contrast, undesirably activated at ectopic sites. When
transgenes are targeted to a known genomic locus such
variation is avoided and expression of the transgene is
significantly more predictable [7]. Such control over the
site and level of expression is important because varia-
tions could have unpredictable impacts on the pheno-
type presented by the transgenic mice.
Introduction of single copy transgenes into the hydroxy-
phosphoribosyl transferase (HPRT) locus has been pre-
viously described by Bronson et al. This approach
successfully overcomes the problems associated with the
integration of variable copy numbers of transgenes into
random genomic locations. However, it is only suitable
for introduction of transgenes to the HPRT locus and, in
addition, requires the availability of HPRT-negative ES
cell lines. Cre-mediated targeting of single copy trans-
genes to specific genomic sites that have previously been
marked by loxP elements has also been described both in
somatic cells and more recently in ES cells using a double
LoxP targeting strategy [22, 23]. Although this approach
also results in efficient targeting to a defined genomic lo-
cus it relies on co-transfection of a Cre expression plas-
mid along with a loxP-targeting vector that carries the
transgene. Hardouin et al also recently described an ele-
gant approach to introduce transgenes to loci identified
by gene trapping. Here integration of the transgene at
the gene-trap locus was again mediated by Cre recombi-
nase and translation of the transgene was facilitated by
an internal ribosomal entry site (IRES) [24]. In contrast,
our approach relies simply on the reconstitution of re-
sistance to G418 and can be used to target transgenes to
any genomic locus.
Transgenic mice are often used to examine gene function
through ectopic expression studies. This requires the
availability of characterized transcriptional regulatory
elements that are capable of expressing transgenes in the
tissue of choice. In addition, for developmental studies,
the transcriptional regulatory elements have to ensure
transgene expression during the correct developmental
time frame. Although the expression patterns of many
genes have been described in detail, characterization of
promoter and enhancer elements that control this ex-
pression is much more limited. This is partly due to the
fact that complex expression patterns often utilize ge-
nomic regulatory sequences that are positioned many
kilobases away from the gene making them difficult to
identify. However, the introduction of transgenes into
specific loci allows the utilization of intact endogenous
transcription regulatory sequences, which increases the
Figure 4
Targeting of a LacZ transgene to the Hnf3α∆ Neo locus. a) A
targeting vector (materials and methods) containing a LacZ
transgene was introduced into Hnf3α∆ pgk-Neo ES cells by
electroporation and cells were cultured in media containing
G418. The genotype of ES cell clones that were resistant to
G418 was determined by Southern blot analysis of genomic
DNA digested with HindIII and EcoRV. A wild type 8.0 kb
Hnf3α  fragment and a 3.5 kb " pgk-Neo targeted" fragment
from Hnf3α∆ pgk-Neo ES cells (lane 1) was identified using
probe A. The 3.5 kb " pgk-Neo targeted" fragment was
replaced with a 2.7 kb EcoRV fragment in all fifteen G418
resistant clones examined due to the introduction of a novel
EcoRV site that lies within the LacZ transgene (Hnf3α LacZ,
lanes 2-16). b) Embryos at 10.5 days of gestation that were
derived from Hnf3α LacZ ES cells express β -galactosidase
(blue) throughout the developing hindgut (hg), foregut (fg),
liver (l) and stomach (s).
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likelihood that the transgene will be expressed in the ex-
pected fashion.
Using targeted ES cells also provides the potential of ex-
pressing lethal transgenes. This may be important for ex-
amining the effects of expressing gain-of-function or
dominant-negative alleles of a gene product. This is dif-
ficult using a conventional approach because of the need
to establish founder mice expressing the transgene.
However, if a line of "transgenic" ES cells can be estab-
lished then it is possible to generate clonal embryos di-
rectly from these ES cells by aggregating them with
tetraploid embryos. Indeed, here we have used this ap-
proach to establish that the introduction of a LacZ trans-
gene into the Hnf3α  locus facilitates transgene
expression throughout the developing gut (Fig 4).
In sum, we have described a method that facilitates the
efficient introduction of transgenes into predefined loci
in the mouse genome. By selecting appropriate sequenc-
es for homologous recombination this approach can be
tailored toward any specific genomic locus. We, there-
fore, believe that this approach expands the repertoire of
tools available for genetic manipulation in the mouse




In the following cloning steps "blunt" infers that the co-
hesive ends of a DNA fragment, cut by restriction endo-
nucleases, were repaired by the Klenow fragment of DNA
PolI in the presence of deoxyribonucleotides.
Hnf3α  targeting vector(p3α loxPNeo-TK)
A 900 bp Xho1/Xba1 fragment of Hnf3α  genomic DNA
that included exon 1 and a portion of intron 1 was used as
the 5' arm of homology. The 3' arm of homology was
cloned as a 4.5 kb Xho1 fragment of Hnf3α  genomic
DNA. A Xho1/HindIII (blunt) cassette containing the
Tn5  neomycin phosphotransferase ( Neo)gene, that
could confer resistance to G418 and whose expression in
mammalian cells was directed by a phosphoglycerate ki-
nase-1 ( pgk) promoter, was introduced into an XbaI
(blunt) site between the Hnf3α  genomic sequences [16,
25]. The pgk promoter was flanked by loxP elements so
that it could be deleted by the action of Cre recombinase.
The  herpes simplex virus thymidine kinase ( hsv-TK)
gene, whose expression was also regulated by the pgk
promoter, was introduced adjacent to the Hnf3α  5' arm
of homology to provide negative selection in the presence
of gancylovir.
Transgene targeting vector (p3α∆ Neo)
The transgene-targeting vector used in these experi-
ments was generated in multiple steps (Fig 2). A NotI/
RsrII (blunt)1.4 kb cassette containing the 5' end of Neo
coding sequence accompanied by the pgk promoter with
flanking loxP elements was introduced into the SphI site
(blunt) of pNEB193 (New England Biolabs). Deletion of
the 49 c-terminal codons of the Neo gene disrupted its
ability to encode resistance to G418 (data not shown)
[16]. This sub-fragment of Neo provided the 3' arm of ho-
mology in the targeting vector. A 530 bp EcoRI fragment
(blunt) containing an intron from the mouse protamine
gene as well as poly(A) addition sequences was isolated
from the plasmid pLacF and cloned into the PmeI site
(blunt) of the preceding plasmid [26]. Finally the 5' arm
of homology was provided by a 4.5 kb Xho I fragment of
Hnf3α  genomic DNA that was introduced into a unique
Pac1 site (blunt) in the preceding plasmid. Importantly,
this fragment extended from 5' genomic DNA into se-
quences encoding the untranslated 5' end of Hnf3α  mR-
NA. This cloning strategy left a unique Sal I site into
which coding sequences of transgenes could be intro-
duced. A NotI (blunt) 3.6 kb lacZ fragment from pCMV-
β gal (Clontech) was ligated into this SalI (blunt) site to
generate a targeting vector that could be used to intro-
duce lacZ into the "marked" Hnf3α  locus.
Culture and selection of embryonic stem cell lines
All ES cell lines were cultured on mitotically inactivated
primary embryonic fibroblasts in ES cell medium sup-
plemented with recombinant leukemia inhibitory factor
(LIF) as described elsewhere [27]. Gene targeting was
carried out using 100 µg of linear targeting plasmid. This
was introduced into 2.5 ×  108 ES cells by electroporation
at 250 volts/500µf/resistance 8 using a BTX ECM600
electroporation system. Cells were plated on thirteen 10
cm2 tissue culture dishes and grown for two days in ES
cell medium supplemented with LIF. Cells containing
Neo were selected by supplementing the ES cell medium
with 300 µg/ml Geneticin (G418,Gibco-BRL) and nega-
tive selection against Hsv-tk gene expression was
achieved by including 2 µM gancyclovir (Roche). Recom-
bination between loxP elements in ES cells was mediated
by introducing a Cre expression plasmid, pHDMCCre8
(provided by Dr. Klaus Kaestner). 100 µg of
pHDMCCre8 was introduced into 5 ×  107 ES cells by elec-
troporation using 400 v/500µf/resistance setting 8. 1/
100,000 of the total electroporated cell population was
plated per 10 cm2 tissue culture dish in ES cell medium
supplemented with LIF and grown until individual colo-
nies could be collected.
Tetraploid aggregation and β -galactosidase staining
Embryos were generated from ES cells by aggregating
them with 4-cell stage embryos made tetraploid by elec-BMC Developmental Biology (2001) 1:10 http://www.biomedcentral.com/1471-213X/1/10
trofusion, as described previously [19, 20, 27]. Aggre-
gates that formed blastocysts after overnight culture
were allowed to continue their development in utero by
transferring them to a pseudopregnant surrogate moth-
er. Embryos were stained for expression of β -galactosi-
dase using standard techniques [28].
Abbreviations
Neo - neomycin phosphotransferase
pgk - phosphoglycerate kinase promoter
Hsv-TK - Herpes simplex virus thymidine kinase
Hnf - hepatocyte nuclear factor
LIF - leukemia inhibitory factor
HPRT - hydroxyphosphoribosyl transferase
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